639 related articles for article (PubMed ID: 33682498)
1. Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.
Mori Y; Hiromura M; Terasaki M; Kushima H; Ohara M; Fukui T; Takahashi Y; Yamagishi SI
J Int Med Res; 2021 Mar; 49(3):300060521996192. PubMed ID: 33682498
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
4. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
Azizi F; Abdi H; Amouzegar A
BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
[TBL] [Abstract][Full Text] [Related]
5. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
7. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
[TBL] [Abstract][Full Text] [Related]
8. A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance.
Li H; Okuda J; Akamizu T; Mori T
Endocr J; 1995 Oct; 42(5):697-704. PubMed ID: 8574295
[TBL] [Abstract][Full Text] [Related]
9. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
10. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low-dose methimazole in control of multiple relapses of Graves' hyperthyroidism: a case report.
Azizi F; Amouzegar A; Abdi H
J Med Case Rep; 2021 Apr; 15(1):189. PubMed ID: 33888159
[TBL] [Abstract][Full Text] [Related]
12. A patient-specific treatment model for Graves' hyperthyroidism.
Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
Yoshihara A; Noh JY; Watanabe N; Kunii Y; Suzuki M; Matsumoto M; Suzuki N; Hiruma M; Morisaki M; Kawaguchi A; Sugino K; Ito K
Thyroid; 2020 Mar; 30(3):451-456. PubMed ID: 31928169
[No Abstract] [Full Text] [Related]
14. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
16. Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
Pirnat E; Zaletel K; Gaberscek S; Fidler V; Hojker S
Nuklearmedizin; 2004 Aug; 43(4):129-34. PubMed ID: 15316580
[TBL] [Abstract][Full Text] [Related]
17. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.
Uchida T; Goto H; Kasai T; Komiya K; Takeno K; Abe H; Shigihara N; Sato J; Honda A; Mita T; Kanazawa A; Fujitani Y; Watada H
Endocrine; 2014 Nov; 47(2):506-11. PubMed ID: 24493028
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
Reinwein D; Benker G; Lazarus JH; Alexander WD
J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
[TBL] [Abstract][Full Text] [Related]
20. The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease.
Gemma R; Nakamura H; Mori T; Andoh S; Suzuki Y; Yoshimi T
Endocr J; 1996 Feb; 43(1):61-6. PubMed ID: 8732453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
